HOUSTON--(BUSINESS WIRE)--Aggredyne, Inc., a Houston-based biomedical diagnostics company, received FDA 510(k) clearance to market its blood platelet aggregometer, the AggreGuide A-100, and its AA (arachidonic acid) Assay that is used to test for aspirin’s effect on platelets.
Help employers find you! Check out all the jobs and post your resume.
